Our group is involved in several key projects aimed at developing new therapeutic strategies for aging, cancer, and neurodegenerative diseases.

Developing novel chemical probes for probing protein functions, with applications in drug discovery and targeted therapy for cancer and neurodegenerative diseases.
Exploring the molecular mechanisms underlying cellular senescence and the senescence-associated secretory phenotype (SASP) in aging and disease, focusing on therapeutic approaches for modulating these pathways.